Latest reports show that the global immunohematology market is expected to reach USD 3.58 billion by 2028, at a CAGR of 5.92% from 2021 to 2028. Immunohematology is a branch of immunology that focuses on the study of blood groups and antigens, as well as the role of antibodies in antigen-antibody reactions. It is mainly used for transfusion medicine and diagnostics. The increasing prevalence of infectious diseases and blood disorders, such as hemolytic disease of the newborn (HDN) and hemophilia, is expected to drive the market growth.
The growing number of hospitals and blood banks, along with the increasing demand for blood transfusion, is also likely to contribute to the growth of the market. The rising awareness of blood donation among individuals is expected to further boost the market growth.
The increasing demand for automated blood banking systems, such as automated blood group analyzers and automated antibody screening systems, is likely to drive the market growth. The increasing technological advancements and the rising demand for point-of-care testing are also expected to fuel the market growth.
The increasing demand for blood components, such as red blood cells, platelets, and plasma, is expected to drive the market growth. These components are used for the treatment of a variety of conditions, such as anemia, thrombocytopenia, and hemorrhage. The rising number of clinical trials for the development of novel blood components is also expected to contribute to the growth of the market.
The increasing prevalence of blood-borne diseases and the rising demand for blood transfusion are expected to drive the market growth. The rising number of blood donation camps and the increasing awareness of blood donation among individuals are also expected to contribute to the growth of the market.
Get Sample PDF Brochure, Click Here
Key players in the market include Ortho Clinical Diagnostics, Grifols, Sysmex Corporation, Immucor, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Biotest AG, and F. Hoffmann-La Roche Ltd.
These companies are focusing on product launches and collaborations to expand their product portfolio and increase their market share. For instance, in 2020, Immucor, Inc. introduced its new automated blood donor screening (ABDS) system, which is designed to improve the speed, accuracy, and reliability of blood donor screening.
The Brainy Insights has segmented the global Immunohematology market on the basis of below mentioned segments:
Global Immunohematology Market by Product:
- Reagents
- Analyzers
Global Immunohematology Market by Application:
- Pretransfusion testing
- ABO and Rh Typing
- Antibody Detection
- Cross matching
- Investigation of immune hemolysis
- Perinatal testing
- Blood group Phenotyping / genotyping
- Leucocyte and platelet Serology
Global Immunohematology Market by Disease:
- Blood-related diseases
- HIV
- Hepatitis
Global Immunohematology Market by End User:
- Hospitals
- Blood banks
- Diagnostic laboratories
Global Immunohematology Market by Region:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Asia-Pacific
- Japan
- China
- India
- South America
- Brazil
- Middle East and Africa
- UAE
- South Africa
